Beyond T2D and weight management in individuals with overweight or obesity, GLP-1 receptor agonists are approved for metabolic dysfunction associated steatohepatitis in people with moderate or advanced fibrosis, obstructive sleep apnea in obese adults, reduction of major adverse cardiovascular events in adults with T2D and cardiovascular disease (CVD), and slowing progression of chronic kidney disease and cardiovascular mortality in adults with both chronic kidney disease and T2D
This acquisition provides Samsung Biologics with immediate, high-volume operational capacity
Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans
The Food and Drug Administration says in its safety profiles of drugs like Ozempic and Wegovy that they should not be taken during pregnancy, noting there is "insufficient data" available
Whichever the measure, the real goal is to get out of the obese range, not necessarily to get out of the overweight range
For the injectable formulation at 2.4 mg, the reported rate was lower but still present: one of 407 patients reported dysesthesia
